{"result": "(\"entity\"<|>EUGOGO<|>ORGANIZATION<|>The European group on Graves' orbitopathy (EUGOGO) focuses on the management and research of Graves' orbitopathy.)\n##\n(\"entity\"<|>BARTALENA L<|>PERSON<|>Bartalena L is a researcher who has contributed to the management of Graves' ophthalmopathy.)\n##\n(\"entity\"<|>PINCHERA A<|>PERSON<|>Pinchera A is a researcher involved in the study of Graves' ophthalmopathy.)\n##\n(\"entity\"<|>MARCOCCI C<|>PERSON<|>Marcocci C is a researcher who has published work on the management of Graves' ophthalmopathy.)\n##\n(\"entity\"<|>HEGEDUS L<|>PERSON<|>Hegedus L is a researcher who has studied the relationship between cigarette smoking and Graves' ophthalmopathy.)\n##\n(\"entity\"<|>BRUNETTO MR<|>PERSON<|>Brunetto MR is a researcher who has investigated liver damage associated with treatment in Graves' ophthalmopathy.)\n##\n(\"entity\"<|>MORABITO E<|>PERSON<|>Morabito E is a researcher who has studied acute liver damage related to glucocorticoid therapy in Graves' ophthalmopathy.)\n##\n(\"entity\"<|>THYROID<|>EVENT<|>Thyroid is a medical journal that published articles on the management and research of Graves' orbitopathy.)\n##\n(\"entity\"<|>ENDOCR REV<|>EVENT<|>Endocrine Reviews is a medical journal that published articles on the management of Graves' ophthalmopathy.)\n##\n(\"entity\"<|>J ENDOCRINOL INVEST<|>EVENT<|>Journal of Endocrinological Investigation published research on the relationship between smoking and Graves' ophthalmopathy.)\n##\n(\"entity\"<|>THYROID<|>EVENT<|>Thyroid is a medical journal that published articles on the management and research of Graves' orbitopathy.)\n##\n(\"entity\"<|>J IMMUNOL<|>EVENT<|>Journal of Immunology published research linking Yersinia enterocolitica to Graves' disease.)\n##\n(\"relationship\"<|>BARTALENA L<|>EUGOGO<|>Bartalena L is a member of EUGOGO and has contributed to its research on Graves' orbitopathy.<|>8)\n##\n(\"relationship\"<|>PINCHERA A<|>EUGOGO<|>Pinchera A is a member of EUGOGO and has contributed to its research on Graves' orbitopathy.<|>8)\n##\n(\"relationship\"<|>MARCOCCI C<|>EUGOGO<|>Marcocci C is a member of EUGOGO and has contributed to its research on Graves' orbitopathy.<|>8)\n##\n(\"relationship\"<|>HEGEDUS L<|>EUGOGO<|>Hegedus L is a member of EUGOGO and has contributed to its research on Graves' orbitopathy.<|>8)\n##\n(\"relationship\"<|>BRUNETTO MR<|>EUGOGO<|>Brunetto MR is a member of EUGOGO and has contributed to its research on Graves' orbitopathy.<|>8)\n##\n(\"relationship\"<|>MORABITO E<|>EUGOGO<|>Morabito E is a member of EUGOGO and has contributed to its research on Graves' orbitopathy.<|>8)\n##\n(\"relationship\"<|>THYROID<|>EUGOGO<|>EUGOGO's research is published in the Thyroid journal, which focuses on thyroid-related diseases including Graves' orbitopathy.<|>7)\n##\n(\"relationship\"<|>ENDOCR REV<|>EUGOGO<|>EUGOGO's research is published in Endocrine Reviews, which focuses on endocrine disorders including Graves' orbitopathy.<|>7)\n##\n(\"relationship\"<|>J ENDOCRINOL INVEST<|>EUGOGO<|>EUGOGO's research is published in the Journal of Endocrinological Investigation, which focuses on endocrine disorders including Graves' orbitopathy.<|>7)\n##\n(\"relationship\"<|>J IMMUNOL<|>EUGOGO<|>EUGOGO's research is published in the Journal of Immunology, which focuses on immunological aspects of Graves' disease.<|>7)\n<|COMPLETE|>", "input": "\n-Goal-\nGiven a text document that is potentially relevant to this activity and a list of entity types, identify all entities of those types from the text and all relationships among the identified entities.\n \n-Steps-\n1. Identify all entities. For each identified entity, extract the following information:\n- entity_name: Name of the entity, capitalized\n- entity_type: One of the following types: [organization,person,geo,event]\n- entity_description: Comprehensive description of the entity's attributes and activities\nFormat each entity as (\"entity\"<|><entity_name><|><entity_type><|><entity_description>)\n \n2. From the entities identified in step 1, identify all pairs of (source_entity, target_entity) that are *clearly related* to each other.\nFor each pair of related entities, extract the following information:\n- source_entity: name of the source entity, as identified in step 1\n- target_entity: name of the target entity, as identified in step 1\n- relationship_description: explanation as to why you think the source entity and the target entity are related to each other\n- relationship_strength: a numeric score indicating strength of the relationship between the source entity and target entity\n Format each relationship as (\"relationship\"<|><source_entity><|><target_entity><|><relationship_description><|><relationship_strength>)\n \n3. Return output in English as a single list of all the entities and relationships identified in steps 1 and 2. Use **##** as the list delimiter.\n \n4. When finished, output <|COMPLETE|>\n \n######################\n-Examples-\n######################\nExample 1:\nEntity_types: ORGANIZATION,PERSON\nText:\nThe Verdantis's Central Institution is scheduled to meet on Monday and Thursday, with the institution planning to release its latest policy decision on Thursday at 1:30 p.m. PDT, followed by a press conference where Central Institution Chair Martin Smith will take questions. Investors expect the Market Strategy Committee to hold its benchmark interest rate steady in a range of 3.5%-3.75%.\n######################\nOutput:\n(\"entity\"<|>CENTRAL INSTITUTION<|>ORGANIZATION<|>The Central Institution is the Federal Reserve of Verdantis, which is setting interest rates on Monday and Thursday)\n##\n(\"entity\"<|>MARTIN SMITH<|>PERSON<|>Martin Smith is the chair of the Central Institution)\n##\n(\"entity\"<|>MARKET STRATEGY COMMITTEE<|>ORGANIZATION<|>The Central Institution committee makes key decisions about interest rates and the growth of Verdantis's money supply)\n##\n(\"relationship\"<|>MARTIN SMITH<|>CENTRAL INSTITUTION<|>Martin Smith is the Chair of the Central Institution and will answer questions at a press conference<|>9)\n<|COMPLETE|>\n\n######################\nExample 2:\nEntity_types: ORGANIZATION\nText:\nTechGlobal's (TG) stock skyrocketed in its opening day on the Global Exchange Thursday. But IPO experts warn that the semiconductor corporation's debut on the public markets isn't indicative of how other newly listed companies may perform.\n\nTechGlobal, a formerly public company, was taken private by Vision Holdings in 2014. The well-established chip designer says it powers 85% of premium smartphones.\n######################\nOutput:\n(\"entity\"<|>TECHGLOBAL<|>ORGANIZATION<|>TechGlobal is a stock now listed on the Global Exchange which powers 85% of premium smartphones)\n##\n(\"entity\"<|>VISION HOLDINGS<|>ORGANIZATION<|>Vision Holdings is a firm that previously owned TechGlobal)\n##\n(\"relationship\"<|>TECHGLOBAL<|>VISION HOLDINGS<|>Vision Holdings formerly owned TechGlobal from 2014 until present<|>5)\n<|COMPLETE|>\n\n######################\nExample 3:\nEntity_types: ORGANIZATION,GEO,PERSON\nText:\nFive Aurelians jailed for 8 years in Firuzabad and widely regarded as hostages are on their way home to Aurelia.\n\nThe swap orchestrated by Quintara was finalized when $8bn of Firuzi funds were transferred to financial institutions in Krohaara, the capital of Quintara.\n\nThe exchange initiated in Firuzabad's capital, Tiruzia, led to the four men and one woman, who are also Firuzi nationals, boarding a chartered flight to Krohaara.\n\nThey were welcomed by senior Aurelian officials and are now on their way to Aurelia's capital, Cashion.\n\nThe Aurelians include 39-year-old businessman Samuel Namara, who has been held in Tiruzia's Alhamia Prison, as well as journalist Durke Bataglani, 59, and environmentalist Meggie Tazbah, 53, who also holds Bratinas nationality.\n######################\nOutput:\n(\"entity\"<|>FIRUZABAD<|>GEO<|>Firuzabad held Aurelians as hostages)\n##\n(\"entity\"<|>AURELIA<|>GEO<|>Country seeking to release hostages)\n##\n(\"entity\"<|>QUINTARA<|>GEO<|>Country that negotiated a swap of money in exchange for hostages)\n##\n##\n(\"entity\"<|>TIRUZIA<|>GEO<|>Capital of Firuzabad where the Aurelians were being held)\n##\n(\"entity\"<|>KROHAARA<|>GEO<|>Capital city in Quintara)\n##\n(\"entity\"<|>CASHION<|>GEO<|>Capital city in Aurelia)\n##\n(\"entity\"<|>SAMUEL NAMARA<|>PERSON<|>Aurelian who spent time in Tiruzia's Alhamia Prison)\n##\n(\"entity\"<|>ALHAMIA PRISON<|>GEO<|>Prison in Tiruzia)\n##\n(\"entity\"<|>DURKE BATAGLANI<|>PERSON<|>Aurelian journalist who was held hostage)\n##\n(\"entity\"<|>MEGGIE TAZBAH<|>PERSON<|>Bratinas national and environmentalist who was held hostage)\n##\n(\"relationship\"<|>FIRUZABAD<|>AURELIA<|>Firuzabad negotiated a hostage exchange with Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>AURELIA<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>FIRUZABAD<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>ALHAMIA PRISON<|>Samuel Namara was a prisoner at Alhamia prison<|>8)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>MEGGIE TAZBAH<|>Samuel Namara and Meggie Tazbah were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>DURKE BATAGLANI<|>Samuel Namara and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>DURKE BATAGLANI<|>Meggie Tazbah and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>FIRUZABAD<|>Samuel Namara was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>FIRUZABAD<|>Meggie Tazbah was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>DURKE BATAGLANI<|>FIRUZABAD<|>Durke Bataglani was a hostage in Firuzabad<|>2)\n<|COMPLETE|>\n\n######################\n-Real Data-\n######################\nEntity_types: organization,person,geo,event\nText: European group on Graves' orbitopathy (EUGOGO) on management of Graves' orbitopathy. Thyroid. 2008;18:333-46.\n- Bartalena L, Pinchera A, Marcocci C. Management of Graves' ophthalmopathy: reality and perspectives. Endocr Rev. 2000;21:168-99.\n- Hegedus L, Brix TH, Vestergaard P. Relationship between cigarette smoking and Graves' ophthalmopathy. J Endocrinol Invest. 2004;27:265-71.\n- Le Moli R, Baldeschi L, Saeed P, Regensburg N, Mourits MP, Wiersinga WM. Determinants of liver damage associated with intravenous methylprednisolone pulse therapy in Graves' ophthalmopathy. Thyroid. 2007;17:357-62.\n- Marino M, Morabito E, Brunetto MR, Bartalena L, Pinchera A, Marcocci C. Acute and severe liver damage associated with intravenous glucocorticoid pulse therapy in patients with Graves' ophthalmopathy. Thyroid. 2004;14:403-6.\n\n## 15 En relación con las posibles causas de la enfermedad de Graves, ¿cuál de los siguientes no ha sido implicado como factor causal o predisponente?\n\nA. Alteraciones en genes inmunorreguladores como CD40.\nB. Tabaquismo.\nC. Infecciones por Yersinia enterocolitica.\nD. Todos los anteriores han sido implicados como sospechosos en la etiología de la enfermedad de Graves.\n\n### COMENTARIO\n\nEn relación con la patogenia de la enfermedad de Graves, análisis genéticos han identificado diversos genes que confieren susceptibilidad para su aparición. Estos incluyen genes codificantes de la tiroglobulina y del receptor de TSH, CTLA4 (cytotoxic T-lymphocyte–associated antigen 4), CD25 y CD40. Por lo tanto, la opción A es correcta.\n\nIgualmente, se han implicado factores ambientales, como la exposición al humo del tabaco, infecciones por Yersinia enterocolitica, exceso de yodo en la dieta y estrés emocional (opciones B y C correctas).\n\nReferencias:\n- Smith TJ, Hegedus L. Graves' disease. N Engl J Med. 2016;375:1552-65.\n- Tomer Y. Mechanisms of autoinmune thyroid diseases: from genetics to epigenetics. Annu Rev Pathol. 2014;9:147-56.\n- Hargreaves CE, Grasso M, Hampe CS, Stenkova A, Atkinson S, Joshua GW, et al. Yersinia enterocolitica provides the link between thyroid-stimulating antibodies and their germline counterparts in Graves' disease. J Immunol. 2013;190:5373-81.\n\n## 16 ¿Cuál de los siguientes no produce hipertiroidismo por activación del receptor de la TSH?\n\nA. Los tumores hipofisarios productores de TSH.\nB. La tiroiditis de De Quervain.\nC. El hipertiroidismo transitorio del embarazo por acción de la gonadotropina coriónica.\nD. Las tres causas mencionadas actúan a través del receptor de la TSH.\n\n### COMENTARIO\n\nEl hipertiroidismo provocado por tumores hipofisarios productores de TSH está causado por la unión de la TSH segregada en exceso por la hipófisis con el receptor de la TSH del tirocito.\n\nEl hipertiroidismo que puede aparecer en el primer trimestre del embarazo está causado por la unión de la gonadotropina coriónica segregada por el tejido placentario con el receptor de la TSH del tirocito, del que es un agonista débil. Esto se debe a que la gonadotropina coriónica guarda homología estructural con la TSH.\n\nEl hipertiroidismo que aparece en la tiroiditis subaguda de De Quervain está causado por la liberación de la hormona tiroidea almacenada en el folículo tiroideo, al romperse este por la infección vírica; su fisiopatología no tiene nada que ver con el receptor de la TSH. Por consiguiente, la respuesta correcta es la B.\n\nReferencias:\n- Yoshimura M, Hershman JM. Thyrotropic action of human chorionic gonadotropin. Thyroid. 1995;5:425-34.\n\n## 17 Respecto al diagnóstico diferencial entre secreción inadecuada de TSH (adenoma hipofisario secretor de TSH) y los cuadros de resistencia a las hormonas tiroideas, una de las siguientes afirmaciones es falsa:\n\nA. La existencia de una mutación del gen del receptor de las hormonas tiroideas apoya el diagnóstico de resistencia.\nB. La elevación de la subunidad α es característica en los tirotropinomas.\nC. En los tirotropinomas es característica la disminución de la concentración de SHBG (globulina fijadora de hormonas sexuales).\nD. Los niveles de TSH se suprimen parcialmente tras la administración exógena de T3 en un\n######################\nOutput:", "parameters": {"model": "gpt-4o-mini", "temperature": 0.0, "frequency_penalty": 0.0, "presence_penalty": 0.0, "top_p": 1.0, "max_tokens": 4000, "n": 1}, "history": null}